Deferasirox Dispersible Tablets Manufacturer & Global Exporter
DEFRATAJ delivers WHO-GMP quality Deferasirox in five strengths — engineered for chronic iron-overload management and trusted across LATAM, Africa, Asia and CIS markets.
About DEFRATAJ
DEFRATAJ is Taj Pharma's branded generic of Deferasirox — a once-daily oral iron chelator indicated for chronic iron overload from blood transfusions in patients with thalassemia, sickle cell disease and myelodysplastic syndromes (MDS). Manufactured at our WHO-GMP facility in Sarigam, Gujarat, every batch is released against full pharmacopoeial specifications.
Available in 100, 125, 250, 400 and 500 mg dispersible tablets — designed to disperse rapidly in water or juice for accurate, weight-based dosing.
Available Strengths
Each strength is a dispersible tablet for oral administration after dispersion in water or juice.
Certifications & Compliance
Manufactured under internationally recognized quality standards.
Inside the WHO-GMP Facility
Validated cleanrooms, controlled change rooms and modern formulation lines.
Engineered for Chronic Iron-Overload Care
Patients receiving regular blood transfusions for thalassemia, sickle-cell disease or myelodysplastic syndromes accumulate iron faster than the body can excrete it. Without effective chelation, transfusional iron deposits in liver, heart and endocrine glands - driving morbidity and mortality. DEFRATAJ (Deferasirox) provides a once-daily oral iron-chelation option that fits long-term treatment programmes.
Why Buyers Choose Taj Pharma
- WHO-GMP, ISO and PIC/S aligned manufacturing facility in Sarigam, Gujarat
- Five strengths (100/125/250/400/500 mg) for accurate weight-based dosing
- Full CTD dossier, stability and analytical packages on request
- Customisable blister formats, pack sizes and private labelling
- Best price direct from manufacturer with reliable shipment timelines